Solasia Pharma K.K. Release: Completion of Phase I Clinical Trial of Sancuso(R) in Japanese Volunteers
10/30/2009 9:30:23 AM
TOKYO--(BUSINESS WIRE)--Solasia Pharma K.K. (http://www.solasia.co.jp), a developer of Western oncology pharmaceuticals in-licensed for commercialization in Asian markets, announced today the completion of a Phase I clinical trial for SP-01 (extended release transdermal granisetron patch; brand name: Sancuso®) in Japanese volunteers.
comments powered by